“According to a new report published by Introspective Market Research, Veterinary Oncology Market by Therapy Type, Animal Type, and End User, The Global Veterinary Oncology Market Size Was Valued at USD 1.2 Billion in 2023 and is Projected to Reach USD 3.1 Billion by 2032, Growing at a CAGR of 11.2% From 2024–2032.”

The veterinary oncology market focuses on the diagnosis, treatment, and management of cancer in companion and livestock animals. It includes therapies such as chemotherapy, immunotherapy, radiation therapy, surgical oncology, and targeted drug treatments. With increasing awareness of animal health and the rising prevalence of cancer in pets, veterinary oncology has emerged as a critical segment of the animal healthcare industry.

Advancements in veterinary diagnostics, growing pet humanization, and increased spending on advanced animal healthcare services are significantly accelerating market growth. Compared to traditional palliative approaches, modern oncology treatments offer improved survival rates, enhanced quality of life, and more personalized care for animals, making them increasingly preferred by veterinarians and pet owners alike.

Additionally, the expansion of specialty veterinary clinics, increasing adoption of pet insurance, and continuous R&D investments by pharmaceutical companies are supporting long-term market expansion globally.

Market Segmentation

The Veterinary Oncology Market is segmented into Therapy Type, Animal Type, and End User.
By Therapy Type, the market is categorized into Chemotherapy, Immunotherapy, Radiation Therapy, Surgery, and Targeted Therapy.
By Animal Type, the market is categorized into Companion Animals and Livestock Animals.
By End User, the market is categorized into Veterinary Hospitals & Clinics, Academic & Research Institutes, and Specialty Oncology Centers.

Growth Driver

The primary growth driver of the veterinary oncology market is the rising prevalence of cancer in companion animals, particularly dogs and cats. Factors such as longer pet lifespans, improved diagnostic capabilities, environmental exposure, and breed-specific genetic predispositions are contributing to higher cancer incidence rates. As pet owners increasingly view animals as family members, there is a growing willingness to invest in advanced cancer treatments. This shift is pushing demand for specialized oncology therapies, precision medicines, and comprehensive cancer care services across developed and emerging markets.

Market Opportunity

A major market opportunity lies in the development of advanced immunotherapies and targeted cancer treatments for animals. With growing research focused on personalized veterinary medicine, pharmaceutical companies and biotech firms are investing in novel monoclonal antibodies, cancer vaccines, and gene-based therapies. Additionally, untapped markets in Asia-Pacific and Latin America, supported by rising pet adoption and improving veterinary infrastructure, present significant growth potential for global and regional players over the forecast period.

Detailed Segmentation

Veterinary Oncology Market, Segmentation

The Veterinary Oncology Market is segmented on the basis of Therapy Type, Animal Type, and End User.

Therapy Type

The Therapy Type segment is further classified into Chemotherapy, Immunotherapy, Radiation Therapy, Surgery, and Targeted Therapy. Among these, the Chemotherapy sub-segment accounted for the highest market share in 2023. Chemotherapy remains widely adopted due to its established clinical efficacy, broad availability, and cost-effectiveness. It is commonly used either alone or in combination with surgery and radiation therapy for treating various animal cancers.

Animal Type

The Animal Type segment is further classified into Companion Animals and Livestock Animals. Among these, the Companion Animals sub-segment accounted for the highest market share in 2023. The dominance is attributed to increasing pet ownership, higher cancer diagnosis rates in dogs and cats, and strong emotional bonds that encourage owners to pursue advanced oncology treatments for their pets.

Some of The Leading/Active Market Players Are-

• Zoetis Inc. (USA)
• Elanco Animal Health Incorporated (USA)
• Boehringer Ingelheim (Germany)
• Merck & Co., Inc. (USA)
• Virbac (France)
• Ceva Santé Animale (France)
• IDEXX Laboratories, Inc. (USA)
• PetCure Oncology (USA)
• Accuray Incorporated (USA)
• Varian Medical Systems, Inc. (USA)
• AB Science (France)
• Oasmia Pharmaceutical AB (Sweden)
• Karyopharm Therapeutics Inc. (USA)

and other active players.

Key Industry Developments

In March 2024, leading veterinary pharmaceutical companies increased investments in oncology-focused R&D initiatives aimed at developing targeted therapies and cancer immunotherapies for companion animals.
These initiatives are expected to improve treatment outcomes, reduce side effects, and expand the availability of personalized cancer care in veterinary medicine.

In September 2023, several specialty veterinary oncology centers expanded their radiation therapy infrastructure across North America and Europe.
This expansion improved access to advanced cancer treatment options, supporting early diagnosis and effective management of complex oncology cases in animals.

Key Findings of the Study

• Chemotherapy remains the dominant therapy segment globally
• Companion animals account for the largest market share
• North America leads due to advanced veterinary infrastructure
• Rising pet humanization is a key growth driver
• Immunotherapy is an emerging high-growth trend

More Info:- https://introspectivemarketresearch.com/reports/veterinary-oncology-market/

About Us

At Introspective Market Research Private Limited, we are a forward-thinking research consulting firm committed to driving growth in the Veterinary Oncology Market. With deep insights, strategic solutions, and holistic research, we empower businesses to achieve success and dominance in the global veterinary healthcare industry.

📞 Contact Us
Introspective Market Research Pvt. Ltd.
Phone: +91-91753-37569
Email: sales@introspectivemarketresearch.com
Web: www.introspectivemarketresearch.com